AXIM Biotechnologies, Inc. (AXIM) stock
AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2024, quarter ended Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
AXIM Biotechnologies market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
AXIM Biotechnologies's market cap was $901.04K on Oct 19, 2026, against $2.94M a year earlier. Over the last 5 years it ranged from $559.47K to $58.84M, with a median of $3.46M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $901.04K | -71.4% |
| 2025 | Dec 31, 2025 | $3.15M | +463.2% |
| 2024 | Dec 31, 2024 | $559.47K | -87.6% |
| 2023 | Dec 29, 2023 | $4.52M | +16.8% |
| 2022 | Dec 30, 2022 | $3.87M | -93.4% |
| 2021 | Dec 31, 2021 | $58.84M | +8.5% |
| 2020 | Dec 31, 2020 | $54.21M | +136.6% |
| 2019 | Dec 31, 2019 | $22.92M | -47.9% |
| 2018 | Dec 31, 2018 | $44.00M | -91.3% |
| 2017 | Dec 29, 2017 | $504.72M | +12.7% |
| 2016 | Dec 30, 2016 | $447.99M | +3693.5% |
| 2015 | Dec 31, 2015 | $11.81M | -96.4% |
| 2014 | Dec 31, 2014 | $330.00M | – |
See a number that looks wrong?